Thyrocare reports 23% revenue growth in Q1

Thyrocare Technologies reported consolidated revenue of INR 193 crores for Q1 FY26, marking a 23% year-on-year increase. Pathology business revenue grew 25% while partnership business rose 36%.

Normalized EBITDA increased 42% to INR 63.35 crores, with profit after tax reaching INR 38.06 crores, up 62% year-on-year. The company's franchisee network exceeded 9,500 outlets, processing 46.9 million tests, a 15% increase.